Viela Bio
company
About
Viela Bio is a clinical-stage biotechnology company pioneering and advancing treatments for severe inflammation and autoimmune diseases.
- 101 - 250
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $282.25M
- Industries
- Biopharma,Biotechnology,Health Diagnostics,Medical,Wellness
- Founded date
- Jan 1, 2017
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Viela Bio is a clinical-stage biotechnology company pioneering and advancing treatments for severe inflammation and autoimmune diseases. The Company’s portfolio selectively targets shared critical pathways that are the root cause of disease. Led by a team of global leaders in inflammation and autoimmunity, Viela Bio strives to be a fully integrated biotechnology company, helping millions of patients worldwide. Viela Bio is located in Gaithersburg, Maryland.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$282.25M
Viela Bio has raised a total of
$282.25M
in funding over 2 rounds. Their latest funding was raised on
Feb 28, 2018 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 28, 2018 | Series A | $282.25M | 1 |
AstraZeneca
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Viela Bio is funded by 1 investors.
AstraZeneca
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
AstraZeneca
|
Yes | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
